Fungal Infections in Hematopoietic Stem-Cell Transplant Patients: A Review of Epidemiology, Diagnosis, and Management.
Document Type
Article
Publication Date
8-19-2021
Publication Title
Therapeutic Advances in Infectious Disease
Abstract
The advent of bone marrow transplant has opened doors to a different approach and offered a new treatment modality for various hematopoietic stem-cell-related disorders. Since the first bone marrow transplant in 1957, there has been significant progress in managing patients who undergo bone marrow transplants. Plasma-cell disorders, lymphoproliferative disorders, and myelodysplastic syndrome are the most common indications for hematopoietic stem-cell transplant. Despite the advances, invasive fungal infections remain a significant cause of morbidity and mortality in this high-risk population. The overall incidence of invasive fungal infection in patients with hematopoietic stem-cell transplant is around 4%, but the mortality in patients with allogeneic stem-cell transplant is as high as 13% in one study. Type of stem-cell transplant, conditioning regimen, and development of graft-
Volume
8
First Page
20499361211039050
Last Page
20499361211039050
Recommended Citation
Rahi MS, Jindal V, Pednekar P, Parekh J, Gunasekaran K, Sharma S, Stender M, Jaiyesimi IA. Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management. Ther Adv Infect Dis. 2021 Aug 19;8:20499361211039050. doi: 10.1177/20499361211039050. PMID: 34434551; PMCID: PMC8381463.
DOI
10.1177/20499361211039050
ISSN
2049-9361
PubMed ID
34434551
